Myomo, Inc.
General ticker "MYO" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $39.1M (TTM average)
Myomo, Inc. follows the US Stock Market performance with the rate: 50.7%.
Estimated limits based on current volatility of 4.3%: low 1.22$, high 1.32$
Factors to consider:
- Total employees count: 295 (+60.3%) as of 2025
- US accounted for 18.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses, Reimbursement changes, Product recalls, Market competition, Strategic risks and growth management
- Price in estimated range
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.61$, 1.82$]
- 2026-12-31 to 2027-12-31 estimated range: [0.62$, 1.75$]
Financial Metrics affecting the MYO estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: -18.95 < Investing cash flow per share per price, % of -17.66
- Positive: 25.20 < Shareholder equity ratio, % of 29.51 <= 34.41
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Interest expense per share per price, % of 2.32 <= 2.54
Short-term MYO quotes
Long-term MYO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $19.24MM | $32.55MM | $40.93MM |
| Operating Expenses | $27.47MM | $38.76MM | $55.33MM |
| Operating Income | $-8.23MM | $-6.21MM | $-14.40MM |
| Non-Operating Income | $0.24MM | $0.39MM | $-0.67MM |
| Interest Expense | $0.00MM | $0.00MM | $0.93MM |
| R&D Expense | $2.64MM | $4.77MM | $6.94MM |
| Income(Loss) | $-7.99MM | $-5.82MM | $-15.07MM |
| Taxes | $0.16MM | $0.37MM | $0.50MM |
| Net Income(Loss)* | $-8.15MM | $-6.18MM | $-15.57MM |
| Stockholders Equity | $8.99MM | $24.71MM | $11.40MM |
| Inventory | $1.80MM | $3.17MM | $3.12MM |
| Assets | $14.58MM | $42.24MM | $38.64MM |
| Operating Cash Flow | $-6.17MM | $-3.29MM | $-14.51MM |
| Capital expenditure | $0.15MM | $1.36MM | $1.74MM |
| Investing Cash Flow | $-2.03MM | $0.26MM | $-7.06MM |
| Financing Cash Flow | $9.71MM | $20.93MM | $11.43MM |
| Earnings Per Share** | $-0.28 | $-0.16 | $-0.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.